Big Pharma's return to business as usual galvanizes Trump administration, divided Congress
Pfizer said its system’s rebates and discounts rise just as fast for patients. “We believe the best means to address affordability of medicines is to reduce the growing out-of-pocket costs that consumers are facing due to high deductibles and coinsurance, ... more >
- The Washington Times - Wednesday, December 26, 2018
No hay comentarios:
Publicar un comentario